Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kamila Kaminska(Lund University), Gabriella Honeth(Lund University)
Cited by 40
Related Papers
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
|Breast Cancer Research|2008|553